Results 181 to 190 of about 8,452 (228)

Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia. [PDF]

Front Pharmacol
Sukkarieh HH, Al Fayez N, Al-Omar HA, Azmi NO, Syed B, Albar RA, Al Bali N.   +6 more
europepmc   +1 more source

Real-world evidence and the future of personalized medicine: a global perspective on data, ethics, and equity. [PDF]

Front Health Serv
Sagkriotis A.
europepmc   +1 more source

RWE in Europe Paper IV: Engaging pharma in the RWE Roadmap [PDF]

, 2017
This paper summarises discussions held at the fourth round-table style meeting with a group of expert stakeholders with experience in specialist disease areas and commissioning of care plus prior experience in the field of real world evidence (RWE). The aim of these meetings was to gain an understanding of the use of RWE across Europe and to develop a ...
Gill, Jennifer, Kanavos, Panos, d'Angela, Daniela, Berger, Karin, Dank, Magdolna, Duncombe, Robert, Fink-Wagner, Antje-Henriette, Hutton, John, Kossler, Ingrid, Podrazilova, Katerina, Thomas, Michael   +10 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Wo RWE tätig ist

1998
Die RWE-Gruppe bekennt sich zum Standort Deutschland, aber auch zur Internationalisierung des Konzerns.
Dieter Schweer, Wolf Thieme
exaly   +2 more sources

Applications of RWE for Regulatory Uses

2022
Eleanor E. Panico, Corinne S. Pillai, Ewa Filipowska, Kelly H. Zou   +3 more
exaly   +2 more sources